Molecular Diagnostics Market Estimated To Grow at a CAGR of 6.1% by 2032 | IMARC Group

IMARC Group's report titled " Molecular Diagnostics Market Report by Product, Technology, Application, End Users, and Region 2024-2032 ". The global molecular diagnostics market size reached US$ 19.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 33.7 Billion by 2032, exhibiting a growth rate (CAGR) of 6.1% during 2024-2032.

Factors Affecting the Growth of the Molecular Diagnostics Industry:

• Technological Innovations:

Technological advancements in molecular biology techniques, such as polymerase chain reaction (PCR) and next-generation sequencing (NGS), provide precise results, which is contributing to the market growth. PCR allows for quicker and more accurate detection of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) sequences. NGS enables high-throughput sequencing, facilitating genomics research and personalized medicine. These advancements benefit in increasing diagnostic accuracy, reducing turnaround times, and lowering costs, making molecular diagnostics more accessible to healthcare providers and patients. Furthermore, miniaturization and automation aids in simplifying laboratory workflows while enhancing efficiency.

• Increasing Prevalence of Infectious Diseases:

The growing demand for molecular diagnostics due to the rising prevalence of various infectious diseases among the masses is offering a positive market outlook. In line with this, molecular diagnostics provide rapid and accurate identification of pathogens like viruses and bacteria, which is strengthening the market growth. Moreover, molecular tests, like PCR-based assays, allow for early detection of pathogens, tracking of their mutations, and monitoring of transmission patterns. Additionally, the increasing need for surveillance and testing in healthcare settings is supporting the market growth.

• Rising Focus on Personalized Medicine:

The rising focus on personalized medicines among the masses is impelling the growth of the market. Apart from this, healthcare providers can tailor treatment plans and medication choices to maximize effectiveness while minimizing side effects by analyzing the genetic makeup and molecular markers of individuals. Additionally, molecular diagnostics enables the identification of specific genetic mutations and biomarkers associated with various diseases, such as cancer, cardiovascular disorders, and neurological conditions. These tests allow clinicians to make informed decisions about targeted therapies, dosage adjustments, and treatment strategies.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/molecular-diagnostics-market/requestsample

Leading Companies Operating in the Global Molecular Diagnostics Industry:

• Abbott Laboratories
• Agilent Technologies Inc.
• Becton Dickinson and Company
• Biomerieux SA
• Danaher Corporation
• Diasorin Molecular LLC (DiaSorin)
• F. Hoffmann-La Roche AG (Roche Holding AG)
• Hologic Inc.
• Illumina Inc.
• Myriad Genetics Inc.
• Qiagen
• Quidel Corporation
• Thermo Fisher Scientific, etc.

Global Molecular Diagnostics Market Report Segmentation:

By Product:

• Reagents and Kits
• Instruments
• Software and Services

Reagents and kits represent the largest segment due to the rising prevalence of chronic diseases among people.

By Technology:

• Polymerase Chain Reactions (PCR)
• Hybridization
• DNA Sequencing
• Microarray
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• Others

Polymerase chain reactions (PCR) accounted for the largest market share as there is an increase in the need for precise genetic analysis.

By Application:

• Infectious Diseases Diagnostics
• Oncology
• Genetic Testing
• Blood Screening
• Others

Infectious diseases diagnostics hold the biggest market share due to the rising focus on preventive healthcare among individuals.

By End User:
• Hospitals
• Laboratories
• Others

On the basis of end user, the market has been divided into hospitals, laboratories, and others.

Regional Insights:

• North America
o United States
o Canada
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Others
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Russia
o Others
• Latin America
o Brazil
o Mexico
o Others
• Middle East and Africa

North America enjoys the leading position in the molecular diagnostics market on account of the increasing awareness among healthcare professionals and patients about the benefits of targeted therapies.

Ask Analyst for Customization: https://www.imarcgroup.com/request?type=report&id=5726&flag=C

Global Molecular Diagnostics Market Trends:

Molecular diagnostics can help in identifying specific genetic mutations and biomarkers associated with different types of cancer, allows for more precise and targeted therapies. Patients benefit from treatments that are tailored as per their unique genetic profiles, leading to improved outcomes and reduced side effects. In addition, the rising demand for molecular diagnostic tests in oncology is propelling the market growth.

The increasing need for rapid and convenient diagnostics among patients is strengthening the market growth. Besides this, key players are developing portable and user-friendly devices that can deliver results in real-time.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Browse More:-

https://www.digitaljournal.com/pr/news/imarc/south-korea-medical-tourism-market-2023-a-valuation-of-us-2-5-billion-predicted-by-2028-imarc-group

https://www.digitaljournal.com/pr/news/imarc/united-states-commercial-insurance-market-size-to-surpass-us-391-5-billion-by-2028-exhibiting-a-cagr-of-6-89-imarc-group

https://www.digitaljournal.com/pr/news/imarc/united-states-printer-market-estimated-to-grow-at-a-cagr-of-4-4-by-2028-imarc-group

https://www.digitaljournal.com/pr/news/imarc/india-battery-market-is-predicted-to-hit-a-cagr-of-10-5-by-2028

Contact Us:

IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

This release was published on openPR.